Quick Answer
Corbus Pharmaceuticals Holdings, Inc. reported Stockholders Equity of $147.50 million for fiscal year 2025.
Corbus Pharmaceuticals Holdings, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $147.50M | +3.6% |
| 2024 | $142.43M | +2162.7% |
| 2023 | -$6.91M | -120.9% |
| 2022 | $32.99M | -52.3% |
| 2021 | $69.11M | +52.6% |
| 2020 | $45.27M | +635.3% |
| 2019 | $6.16M | -77.6% |
| 2018 | $27.52M | -52.4% |
| 2017 | $57.78M | +547.9% |
| 2016 | $8.92M | -0.7% |
| 2015 | $8.99M | +53.3% |
| 2014 | $5.86M | +428.8% |
| 2013 | -$1.78M | -50.2% |
| 2012 | -$1.19M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $92.15M | -38.8% | -17.0% |
| June 30, 2025 | $110.99M | -11.6% | -12.7% |
| March 31, 2025 | $127.11M | +31.1% | -10.8% |
| December 31, 2024 | $142.43M | +2162.7% | -5.4% |
| September 30, 2024 | $150.50M | +48136.5% | +19.9% |
| June 30, 2024 | $125.54M | +1218.6% | +29.5% |
| March 31, 2024 | $96.97M | +489.1% | +1504.3% |
| December 31, 2023 | -$6.91M | -120.9% | -2313.1% |
- Corbus Pharmaceuticals Holdings, Inc. showed an increase of +3.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2012–2025 period, Corbus Pharmaceuticals Holdings, Inc.’s stockholders equity has grown by 12526.7% (from -$1.19 million to $147.50 million).
- The most recent figure is from Corbus Pharmaceuticals Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: